GAB1 expression appears to be deregulated in a wide variety of tumors such as thyroid cancer, cervical cancer, breast cancer, meningiomas, cholangiocarcinoma, medulloblastomas, chronic lymphocytic leukemia, head and neck cancer, and colorectal cancer, among others (Figure 4). This evidence concerns the gene GAB1 and breast cancer.